About

We welcome you to participate in the premier international meeting on ‘Cytokines’ that takes place worldwide and is regularly attended by 750-1,000 participants. The 11th edition comes at a time where cytokine biology, cytokine biomarkers and cytokine therapeutics are revolutionizing modern medicine, providing novel treatments for a wide variety of diseases ranging from lethal inflammatory, autoimmune and allergic diseases to viral infections and cancer. This year’s theme is “Cytokines and interferons in the precision medicine era”, focusing on the latest developments on cytokine biology in relation to immune regulation, host damage and disease, and the latest progress on cytokines/cytokine inhibitors as novel therapeutics in the clinic. The Cytokines Annual Meetings are recognized as an international platform for the world’s leading experts discussing cutting-edge updates on cytokine signaling and function and translation into cytokine-based therapeutics and immune-modifying biologics. The meeting bridges the gap between the scientists performing basic research and those working to harness this knowledge to develop strategies for interventions– and how all of these translate into emerging therapies.

In recent years, research presented at this meeting has had practical application to a wide range of clinical areas. Showcasing excellent research in autoimmune disease, inflammation, cancer, infectious disease, metabolism, microbiome health, and development, many of the major advances in cytokine biology were first reported at this annual conference.

We hope you will join us in Athens this year to make new contacts, renew friendships and spur this most promising area of research to the next level and ultimately benefitting patients’ healthcare worldwide.

Sincerely,

Cytokines 2023 Local Organizing Committee:

Evangelos Andreakos, PhD, Biomedical Research Foundation, Academy of Athens, Athens, Greece, Program Chair

George N. Pavlakis, MD, PhD, National Cancer Institute/NIH, Bethesda, USA, Co-Chair

Federica Sallusto, PhD, Institute for Research in Biomedicine, Bellinzona, Switzerland

Irini Sereti, MD, MHS, National Institutes of Health, Bethesda, USA

Athanasios Tzioufas, MD, School of Medicine, University of Athens, Greece